28
Sep
Technology and AI
From Phase 2 to reimbursement, we make sure your product’s value is clear and understood.

Healthcare product launches
The story of your product will be told. The question is whether it’s told with you, or without you. Too often, misconceptions take hold before launch, making it harder to set the record straight later.
That’s why we help you get the narrative right early, shaping evidence into a clear, compelling value story that resonates with regulators, payers, healthcare professionals and patient organisations. With senior consultants leading every step, we navigate Europe and the UK’s complex pathways to deliver launch excellence.
Vaccines and the JCVI – done it. Coordinating EMA and MHRA authorisation announcements for a drug – been there. Navigating orphan drug pathways – one of our favourites. Collaborating with NICE to generate maximum media coverage – tick. DTC launch to drive e-commerce sales for a consumer health brand – yep.
We have years of experience in launch excellence across pharma, biotech, med tech and device and consumer health brands. We have lived the different regulatory processes, compliance considerations and routes to market. We anticipate the hurdles and maximise opportunities so your value story lands with stakeholders.
What we do
Understand the potential value of your product to stakeholders.
Take every opportunity to share your value story.
Fully prepare all stakeholders for the reimbursement journey.
Equip customers with the tools to implement HTA guidance.
Related insights